Proteinuria as a Risk Marker for the Progression of Chronic Kidney Disease in Patients on Predialysis Care and the Role of Angiotensin-Converting Enzyme Inhibitor/Angiotensin II Receptor Blocker Treatment

Author(s):
Goeij, M.C.M. de; Liem, M.; Jager, D.J. de; Voormolen, N.; Sijpkens, Y.W.J.; Rotmans, J.I. (0000-0001-9682-6234); Boeschoten, E.W.; Dekker, F.W. (0000-0002-2433-2494); Grootendorst, D.C.; Halbesma, N.; PREPARE-1 Study Grp
Published
2012
Publication type
Article / Letter to editor
Chronic kidney disease stages IV-VPredialysis careProteinuriaACEi/ARBsDecline in renal functionRenal replacement therapy
Date issued
2012-12-31
Language
English
Is part of
Nephron Clinical Practice (2012), Vol. 121, no. 1-2, p. C73-C82
hdl
1887/97014
doi
10.1159/000342392